An interventional study of CPAP treatment and No CPAP treatment in Sleep Apnea, Obstructive, Sleep Apnea Syndromes and Child Behavior Disorders, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 5 Years to 12 Years. Per ClinicalTrials.gov, last updated 2019-01-14.
Sponsored by University of Michigan · Not applicable, Interventional, and Treatment
Obstructive sleep-disordered breathing (SDB) affects 2-3% of children and may lead to problems with nighttime sleep and daytime behavior, learning, sleepiness, and mood. Adenotonsillectomy (AT) is the second most common surgical procedure in children. It is now performed more often for suspected SDB than for any other indication. However, recent studies indicate that many if not most children still have SDB after AT, and many still have learning or behavioral problems associated with SDB. The goals of this study are: (1) to assess the extent that behavior, cognition, and sleepiness in children can improve with Continuous positive airway pressure (CPAP) treatment after AT, and (2) to identify which patients stand to gain most from post-operative assessment and treatment.
Obstructive sleep-disordered breathing (SDB) affects at least 2-3% of children and may have substantial adverse impact on behavior and cognition. Adenotonsillectomy (AT), the second most common surgical procedure in children, is now performed more often for suspected SDB than for any other indication. However, recent studies among an increasingly obese population now show something alarming: many if not most children still have SDB after AT, and many still suffer from residual neurobehavioral morbidity. Furthermore, the investigators' ongoing, 12-year, NIH-funded research has shown that standard preoperative polysomnographic measures of SDB do not consistently predict post-AT improvement in behavior and cognition. This may arise in part because many children after AT still have SDB, and because linear relationships between standard SDB measures and neurobehavioral morbidity may not exist. Even at subtle levels, SDB may promote significant neurobehavioral morbidity. Some have suggested that polysomnography may be more important after AT than before AT. However, in practice few children receive polysomnography before AT, and even fewer after AT, when continuous positive airway pressure (CPAP) could still provide definitive relief from SDB. Preliminary data from our group suggest that CPAP after AT is well-tolerated by most children and may provide significant benefit. However, virtually no published evidence exists to address critical clinical questions: which children benefit most from CPAP after AT; what role can clinical symptoms or polysomnography play in that determination; and what neurobehavioral gains are achieved by CPAP after AT?
The investigators therefore will undertake a highly practical, clinical study with two main goals: (1) to assess the extent that behavior, cognition, and sleepiness in children can improve with CPAP after AT, and (2) to identify which patients stand to gain most from post-operative assessment and treatment. This research will use reversible SDB-related neurobehavioral morbidity as the criteria by which to judge the utility of clinical symptoms and polysomnography in identification of candidates for CPAP after AT.
2,240 studies on the registry are indexed under Sleep Apnea, Obstructive; 475 are open to participants now.
This study's enrollment of 120 is above the median of 52 across 1,472 interventional studies indexed under Sleep Apnea, Obstructive.
Browse Sleep Apnea, Obstructive studies →University of Michigan is the lead sponsor of 1,506 studies on the registry; 192 are open to participants now.
Of its 169 completed or terminated interventional studies of FDA-regulated products, 133 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Certain medications that affect sleepiness or alertness, for example:
Children randomized to this arm will receive 6 months of CPAP (or BPAP) treatment, beginning at approximately 4 months after AT, in addition to standard of care. For analysis purposes those children who were non-adherent (CPAP use \<4 hours per night) vs. adherent (CPAP use at least 4 hours per night) will be analyzed separately.
Procedure: CPAP treatment
Children randomized to this comparison arm will not be treated with CPAP or BPAP, but will be followed for approximately 10 months after AT while receiving standard of care.
Other: No CPAP treatment
6 months of treatment with PAP (CPAP or BPAP)
Also known as: Continuous positive airway pressure device (CPAP), Bi-level positive airway pressure device (BPAP), Positive Airway Pressure device (PAP)
Children randomized to the comparison group will receive routine care
Also known as: Comparison group, Control group
Change in Behavioral Index After 6 Months of CPAP or No-CPAP
The sum of the T-scores of The Conners' Parent Rating Scales (CPRS-R:L, ADHD index) and the Child Behavior Checklist (CBCL, Attention Deficit/Hyperactivity Problems) are used to construct the primary study outcome measure Behavioral Index. Behavioral index is a T score (adjusted for age and gender) with a range of "\<10" to "\>90" - where higher scores mean worse behavior and lower scores mean better behavior, so a negative change score represents an improvement in behavior. T-scores with a mean of 50 and SD of 10 are computed.
Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Change in Cognition as Shown by NIH Toolbox Composite Score
Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40 and Maximum value 160. Higher scores are better
Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Change in Sleepiness as Measured by Epworth Sleepiness Scale
Epworth Sleepiness Scale scores range from 0 to 24 where higher scores mean greater sleepiness.
Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)
Multiple Sleep Latency Test (MSLT) is an objective measure of sleepiness determined by measure of brain waves and other physiological signals over a 30 minute period. This is measured for five 30 minute periods across the day and average latency to sleep for each participant across those times were used to calculate the mean sleep latency. The score is measured in how quickly one would fall asleep, measured in minutes, so a negative number of minutes in the change score means that participants fell asleep more quickly than previously.
Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Change in Quality of Life as Measured by Peds QL
Peds-QL is a quality of life symptom measurement with a score range of 0 to 100. Higher scores are better quality of life
Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
CPAP Adherence as Measured by Number of Participants Who Used the CPAP Consistently.
CPAP adherence data will be downloaded from CPAP machines. It is defined for this study as using the CPAP machine for at least an average of 4 hours per night during the last 60 days of the assignment.
Time frame: Starting at 4 months after AT and continuing through 10 months after AT
Change in Cognition as Measured by Fluid Cognition Scores
Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40, Maximum value 160. Higher scores are better
Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Change in Cognition After AT as Shown by Academic Achievement
Academic achievement mean score is a standardized score with a mean of 100 and SD 15. Minimum value 40 and Maximum value 160. Higher scores are better
Time frame: assessed as change from baseline to 6 months of CPAP therapy or no-CPAP
Of 120 consented, 105 were randomized to CPAP or control. (Of the 15 who weren't randomized, 8 were lost to follow up; the other withdrew for various reasons)
| Milestone | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Adherent) | CPAP After Surgery (Non-adherent) |
|---|---|---|---|
| Started | 34 | 38 | 33 |
| Crossed over to control | 0 | 0 | 2 |
| Had cpap titration | 0 | 38 | 30 |
| Initiated cpap treatment at home | 0 | 38 | 28 |
| Completed as a control | 33 | 0 | 1 |
| Completed | 33 | 38 | 25 |
| Not completed | 1 | 0 | 8 |
| Withdrew: Withdrawal by subject | 1 | 0 | 3 |
| Withdrew: Lost to follow-up | 0 | 0 | 4 |
| Withdrew: Physician decision | 0 | 0 | 1 |
The sum of the T-scores of The Conners' Parent Rating Scales (CPRS-R:L, ADHD index) and the Child Behavior Checklist (CBCL, Attention Deficit/Hyperactivity Problems) are used to construct the primary study outcome measure Behavioral Index. Behavioral index is a T score (adjusted for age and gender) with a range of "\<10" to "\>90" - where higher scores mean worse behavior and lower scores mean better behavior, so a negative change score represents an improvement in behavior. T-scores with a mean of 50 and SD of 10 are computed.
| T score | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Non-adherent) | CPAP After Surgery (Adherent) |
|---|---|---|---|
| Change in Behavioral Index After 6 Months of CPAP or No-CPAP | -2.7 ± 5.8 | .9 ± 4.8 | -1.2 ± 6.3 |
Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40 and Maximum value 160. Higher scores are better
| score on a scale | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Non-adherent) | CPAP After Surgery (Adherent) |
|---|---|---|---|
| Change in Cognition as Shown by NIH Toolbox Composite Score | 5.5 ± 9.5 | 2.8 ± 9.8 | 3.9 ± 7.8 |
Epworth Sleepiness Scale scores range from 0 to 24 where higher scores mean greater sleepiness.
| score on a scale | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Non-adherent) | CPAP After Surgery (Adherent) |
|---|---|---|---|
| Change in Sleepiness as Measured by Epworth Sleepiness Scale | -1.6 ± 3.7 | -1.0 ± 2.2 | -1.9 ± 3.8 |
Multiple Sleep Latency Test (MSLT) is an objective measure of sleepiness determined by measure of brain waves and other physiological signals over a 30 minute period. This is measured for five 30 minute periods across the day and average latency to sleep for each participant across those times were used to calculate the mean sleep latency. The score is measured in how quickly one would fall asleep, measured in minutes, so a negative number of minutes in the change score means that participants fell asleep more quickly than previously.
| minutes | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Non-adherent) | CPAP After Surgery (Adherent) |
|---|---|---|---|
| Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT) | -1.8 ± 4 | -1.3 ± 5.1 | -1.1 ± 4.3 |
Peds-QL is a quality of life symptom measurement with a score range of 0 to 100. Higher scores are better quality of life
| score on a scale | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Non-adherent) | CPAP After Surgery (Adherent) |
|---|---|---|---|
| Change in Quality of Life as Measured by Peds QL | 4.1 ± 9.0 | 0.5 ± 10.2 | 2.4 ± 12.1 |
CPAP adherence data will be downloaded from CPAP machines. It is defined for this study as using the CPAP machine for at least an average of 4 hours per night during the last 60 days of the assignment.
| Participants | CPAP Group |
|---|---|
| CPAP Adherence as Measured by Number of Participants Who Used the CPAP Consistently. | 38 |
Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40, Maximum value 160. Higher scores are better
| score on a scale | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Non-adherent) | CPAP After Surgery (Adherent) |
|---|---|---|---|
| Change in Cognition as Measured by Fluid Cognition Scores | 6.7 ± 12.4 | 1.7 ± 11.5 | 3.4 ± 10.1 |
Academic achievement mean score is a standardized score with a mean of 100 and SD 15. Minimum value 40 and Maximum value 160. Higher scores are better
| units on a scale | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Non-adherent) | CPAP After Surgery (Adherent) |
|---|---|---|---|
| Change in Cognition After AT as Shown by Academic Achievement | -1.0 ± 5.6 | 1.1 ± 4.7 | -2.5 ± 8.6 |
Collected over Adverse events were followed from consent (which could be before surgery or after surgery) until 10 months after surgery equating to six months after assignment.. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| CPAP Treatment Group on CPAP | 0/69 (0%) | 6/69 (8.7%) | 59/69 (85.5%) |
| No CPAP Treatment Group | 0/36 (0%) | 7/36 (19.4%) | 26/36 (72.2%) |
| Non-randomized Participants | 0/15 (0%) | 4/15 (26.7%) | 7/15 (46.7%) |
| Event | CPAP Treatment Group on CPAP | No CPAP Treatment Group | Non-randomized Participants |
|---|---|---|---|
| Post-operative hospitalizationSurgical and medical procedures | 4/69 | 7/36 | 4/15 |
| Hospitalization for ashthmaRespiratory, thoracic and mediastinal disorders | 1/69 | 0/36 | 0/15 |
| ER admission due to panic attackPsychiatric disorders | 1/69 | 0/36 | 0/15 |
| Event | CPAP Treatment Group on CPAP | No CPAP Treatment Group | Non-randomized Participants |
|---|---|---|---|
| Skin IrritationSkin and subcutaneous tissue disorders | 42/69 | 12/36 | 0/15 |
| Cold SymptomsGeneral disorders | 38/69 | 16/36 | 2/15 |
| Unrelated AccidentInjury, poisoning and procedural complications | 22/69 | 9/36 | 1/15 |
| Asthma ExacerbationRespiratory, thoracic and mediastinal disorders | 17/69 | 5/36 | 0/15 |
| AnxietyPsychiatric disorders | 12/69 | 8/36 | 0/15 |
| Stomach FluGastrointestinal disorders | 14/69 | 5/36 | 0/15 |
| Upper Respiratory InfectionInfections and infestations | 7/69 | 6/36 | 2/15 |
| Behavior IssuesSocial circumstances | 11/69 | 4/36 | 0/15 |
| Allergic ReactionImmune system disorders | 8/69 | 5/36 | 0/15 |
| Life Event or ChangeSocial circumstances | 2/69 | 5/36 | 1/15 |
| Age, Continuous(years) | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Adherent) | CPAP After Surgery (Non-adherent) | Total |
|---|---|---|---|---|
| Mean | 7.9 ± 2.0 | 8.3 ± 2.2 | 8.0 ± 2.0 | 8.1 ± 2.1 |
| Sex: Female, Male(Participants) | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Adherent) | CPAP After Surgery (Non-adherent) | Total |
|---|---|---|---|---|
| Female | 13 | 21 | 16 | 50 |
| Male | 21 | 17 | 17 | 55 |
| Ethnicity (NIH/OMB)(Participants) | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Adherent) | CPAP After Surgery (Non-adherent) | Total |
|---|---|---|---|---|
| Hispanic or Latino | 5 | 2 | 0 | 7 |
| Not Hispanic or Latino | 29 | 36 | 33 | 98 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Adherent) | CPAP After Surgery (Non-adherent) | Total |
|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 |
| Asian | 1 | 1 | 1 | 3 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 |
| Black or African American | 1 | 5 | 8 | 14 |
| White | 28 | 29 | 19 | 76 |
| More than one race | 4 | 3 | 5 | 12 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 |
| Region of Enrollment(Participants) | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Adherent) | CPAP After Surgery (Non-adherent) | Total |
|---|---|---|---|---|
| United States | 34 | 38 | 33 | 105 |
| Behavioral Index(units on a scale (T-Score)) | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Adherent) | CPAP After Surgery (Non-adherent) | Total |
|---|---|---|---|---|
| Mean | 61.6 ± 13.4 | 56.5 ± 11.3 | 57.8 ± 11.6 | 58.5 ± 12.1 |
| NIH Toolbox Age adjusted composite score(units on a scale) | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Adherent) | CPAP After Surgery (Non-adherent) | Total |
|---|---|---|---|---|
| Mean | 95.7 ± 11.9 | 96.2 ± 12.3 | 93.9 ± 11.6 | 95.1 ± 11.6 |
| Epworth Sleepiness Scale(units on a scale) | Control Group (Surgery Only - no CPAP) | CPAP After Surgery (Adherent) | CPAP After Surgery (Non-adherent) | Total |
|---|---|---|---|---|
| Mean | 7.2 ± 4.6 | 6.9 ± 3.9 | 6.4 ± 3.0 | 6.8 ± 3.9 |
6 further baseline measures are reported on the registry.
PDFs hosted by the registry, ClinicalTrials.gov.
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.